The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IIb trial of docetaxel concurrent with radiotherapy plus hormotherapy versus radio hormonotherapy in high-risk localized prostate cancer (QRT SOGUG trial): Preliminary report for design, tolerance, and toxicity.
 
Enrique Gallardo Diaz
No Relationships to Disclose
 
Joan Carles
No Relationships to Disclose
 
Montserrat Domenech
No Relationships to Disclose
 
Albert Font
No Relationships to Disclose
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Begoña Mellado
No Relationships to Disclose
 
Cristina Suárez
No Relationships to Disclose
 
Teresa Bonfill
No Relationships to Disclose
 
M Isabel Saez
No Relationships to Disclose
 
Marta Guix
No Relationships to Disclose
 
Maria Jose Mendez
No Relationships to Disclose
 
Pablo Maroto
No Relationships to Disclose
 
Teresa de Portugal
No Relationships to Disclose
 
Mariona Figols
No Relationships to Disclose
 
Raquel Luque
No Relationships to Disclose
 
Ramon Aldabo
No Relationships to Disclose
 
Rafael Morales
No Relationships to Disclose
 
Marta Bonet
No Relationships to Disclose
 
Xavier Maldonado
No Relationships to Disclose
 
Palmira Foro
No Relationships to Disclose